Compositions and methods of treating cardiac fibrosis with ifetroban
US10583126B2 · kind B2 · utility
0Cited by
16References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 23, 2019 |
| Grant date | Mar 10, 2020 |
| Priority date | — |
| Expiry date | Apr 23, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.